GN Flashcards
FSGS causes?
idiopathic
Familial: NPHS1 (nephrin), NPHS2 (podocin), WT1
Infection: HIV, B19, SV40, CMV
Drug induced: Pamidronate, Sirolimus, heroin, interferon, Lithium, anabolic steroid, TKI
reduced renal mass: unilateral renal agenesis, oligomeganephroia, VLBW, renal dysplasia, reflux nephropathy, CAN, sequela to cortical necrosis, advanced renal disease
normal renal mass: HT, RAS, obesity, CRHD, sickle cell
FSGS sym?
HT, microhematuria, proteinuria (non selective), occ glucouria, aminoaciduria, PO4uria, conc defect
FSGS subtypes?
- NOS: accumulation of ECM that occlude glom capillary, forming discrete segmental solidifications
IF shows IgM, C3 - perihilar: SS and hyalinosis at vascular pole, usually in 2nd FSGS
- cellular: segmental endocapillary hypercellularity, usually 1st FSGS
- collapsing: at least 1 segmental or global collapse, prominent IFTA, commonly by HIV, B19, lupus podocytopathy, hemophagocytic syndrome, IF therapy, TKI pamidronate
- tip: adhesion to pole
- diffuse mesangial hypercellularity, IF IgM, C3 EM extensive foot process effacement; exclusively no children
C1qN: dominant or codominant C1q stain with LM FSGS or MCD like, need to exclude LN
Diff 1st and 2nd FSGS?
- HIV: tubular microcyst, EM tubuloreticular inclusion
- adaptive: glomerulomegaly, perihilar lesion, EM foot process effacement tends to be mild
- loss of renal mass: background global GS, IFTA, arteriosclerosis
- SCD: capillary congestion by sickled erythrocyte, double contour of GBM
FSGS prognosis?
some spontaneously remit, unresponsive case to ESRD in 5 - 20 years
worst for collapse, best for tip, NOS an cellular middle
FSGS Tx?
subnephrotic: BP < 125 / 75, ACEI, statin, low protein
nephrotic: + Pred 1mg/kg/d x 4 - 16wks then taper over 6m
SR or CI to steroid: CsA 3-5mg/kg/d x 4 - 6m, FK 2-4 bd x 4-6m, CYC 2mg/kg/d x 2-4m, MMF 1-1.5g bd x 4-6m
? RTX, Abatacept, ACTH
MN patho features?
LM: thickening of glom capillary wall, spike in silver stain
IF: diffuse finely granular IC IgG (IgG4, if other Ig suggest LN / 2nd cause) and EDD in subepithelial space, C3 common, C1q suggest LN, PLA2R suggest 1st, mesangial Ig present suggest 2nd
EM: subepithelial deposit without subendothelial
MN causes?
Anti PLA2R
Anti THSD7A
Autoimmune: Class V LN, uncommon RA, autoimmune thyroid, IgG4, Anti GBM, ANCA
Infection: HBV, common HCV, HIV, syphilis, schistosomiasis
malignancy: solid tumor, uncommon NHL, CLL, melanoma
Drug: NSAID, PPI, uncommon Hg, gold, D penicillamine
Other: sarcoidosis, GVHD, post transplant
MN typical age and sex?
M:F 2:1, peak 40s - 50s
MN features?
nephrotic, microscopic hematuria common but RBC cast rare, 10% HT, Cr n
MN Ix?
BP, RFT, urinalysis, 24hr uP, LDL, Anti PLA2R, HBV,HCV, ANA, dsDNA, C3, C4
doppler / MRA / CTA if frankl pain hematuria AKI
Anti GBM and ANCA if active urine
cancer screening if > 50y/o
NS ddx
DM, MCN, FSGS, MN, MPGN (IC or C3), amyloid / LCDD, LN
MN Tx?
BP 125 / 75 with ACEI
statin
low protein diet
anticoagulate if Alb < 25
immunosuppresant if uPCR > 4 without 50% decline over 6m despite ACEI (unless disabling or llife threatening sym or Cr rise 30% over 12m after r/o RVT / crescentic variant / AIN (or 3m if heavy NS >8g)
- Ponticelli: MP 1g x 3 days then pred 0.5mg/kg/d for 1,3,5m; CYC 2mg/kd/d 2,4,6m
- CNI: CsA 3.5-5mg/kg/d + 0.15mg/kg/d Pred x 6m, or FK 0.05-0.075mg/kg/d x 6m
? RTX / ACTH
Diff TTP and HUS?
TTP more severe low plt and less severe AKI
HUS causes?
typical:
- Shiga toxin bacteria (STE Coli, shigella)
- Strep pneumoniae (neuraminidase related)
Atypical:
- familial: CFH, C3, MCP, THBD, CFB, CHF / CHFR hybrid, DGKE
- sporadic
- idiopathic
- pregnancy related / HELLP
- Transplant
TTP cause?
congenital: homozygous / compound heterozygous mutation in ADAMTS13
Acquired: Anti ADAMTS13 AutoAb
TMA causes?
HUS / TTP Cobalamin C deficiency (MMACHC mutation) Drug induced: Ticlopidine and plavix: Anti ADAMTS13 BM / HSC transplant Malignancy HIV SLE, APS malignant HT scleroderma
TTP pentad?
fever, MAHA, fever, CNS AKI
Diff TMA from DIC?
normal PT, APTT, fibrinogen, coagulation factor
MIDD secondary cause?
MM, waldenstrom, CLL, NHL
MIDD sym?
hematuria, proteinuria may be NS, CKD or RPGN, hepatosplenomegaly, CHf, arrhythmia, neuropathy, GI upset, lung nodules, arthropathy
MIDD patho features?
eosinophilic tubular lesions, refractile, PAS+ ribbon like
or nodular GS
cresecent possible
arterial and ptc can have PAS+ deposit
IF mainly kappa
EM coarsely / fine granular EDD in tubular, BM or subendothial in GBM
MIDD Tx?
underlying cause
Melphalan +/- ASCT
Diff amyloid, fibrillary and Immunotactoid in patho?
congo red only in amyloid
size of deposit: amyloid 8 - 15nm, FGN 12-22, IGN > 30
alignment of deposit: only IGN are parallel
Ig: Amyloid LC lambda, FGN polychonal IgG4, IGN monoclonal IgGk or IgGL
extrarenal: amyloid systemic, FGN lung hemorrhage,
Asso with other disease: amyloid: MM, FGN: MM, IBD, SLE, IGN NHL, CLL
Tx: amyloid: mephalan + dexa, FGN steroid+/- CYC, IGN treat PLD
SLE Dx?
SLICC ACR Criteria: 4 of following, at least 1 clinical and 1 immunological criteria OR biopsy proven LN with ANA / dsDNA+
Clinical: acute / subacute cutaneous lupus, chronic cutaneous lupus, non scarring alopecia, oral / nasal ulcer, synovitis > 2 joints, serositis, renal disease (RBC cast / uPCR > 0.5g/d), neurological disorder, hemolytic anaemia, leukppenia OR lymphopenia, thrombocytopenia
Immunological criteria: ANA, dsDNA, APAb+, low C3 / C4, DAT+ without hemolytic anaemia,
Drug induced SLE?
procainamide, hydralazine, quinidine, Anti TNF
patho in LN?
I: normal LM, mesangial deposit in IF
II: LM mesangial hypercellularity
III: LM endocapillary or extracapillary GN in < 50% glom
IV: same as III with > 50%
V: GBM thickening with subepitheliam and mesangial IC
IV 90% sclersed
LN Tx?
III or IV:
PRed 0.5 - 1mg/kg/d titrate down in 6-12m +/- MP 1g 1-3days
NIH regime: IV CYC 0.5-1g/m2 monthly x 6
Euro-Lupus: IV CYC 500mg, Q2weeks x 3 months
PO CYC: 1-1.5mg/kd/d (Max 150mg/d) x 3 months
MMF up to 3g/d x 6m
If refractory: RITUXILUP: RTX 1g x 2,
FK / CsA, IVIG, TPE
? Abatacept CTLA4 fusion protein
maintainence: MAINTAIN: MMF 1-2g/d or AZA 1-2.5mg/kd/d or CsA 2.5-4mg/kd/d or FK to trough 4-6ng/ml
V and NS / AKI / persistently < 1g despite ACEI:
MMF 2-3g/d or AZA 1-2.5mg/kg/d +/- steroid x 6m
Alt use IV CYC 0.5-1g/,2 monthly x 6 / CsA 4-6mg/d x 12m / FK 0.1-0.2mg/kd/d x 12 m
CR / PR LN Def?
CR: < 0.5g/d proteinuria with no glom hematuria / RBC cast, normal GFR
PR: 50% reduction in proteinuria in subnephrotic range, stable GFR
what is C1q nephropathy
C1q predom in IF
can be MCN or FSGS spectrum
to r/o SLE
IRGN Tx?
Treat underlying infection
MP if extensive crescent or severe RPGN
type of cryoglobulemic GN?
I: monoclonal Ig - M>G>A>BJP: MM, CLL, Waldenstrom
II: mixed cryoglobulin with monoclonal Ig - M/G»_space; G/G: infection HCV, Sjogren, CLL, lymphoma)
III: Mixed polyclonal - M/G: Infection (HCV / HBV), SLE, RA, vasculitis, malignancy
Cryoglobulinemic GN sym?
palpable non puruitic pupura, arthralgia (not arthritis), PN, AKI
CHF, digital necrosis, lung infiltrate, mesenteric ischemica
type I usually asymptomatic
Ix for cryoglobulinemic GN?
low C3 with C3 normal or mildly low, RF+, 40% type II cryo -ve
cryoglobulinemic GN patho?
MPGN 80%, more macrophage than normal poliferative GN, intraluminal thrombi possible,
IF diffuse IgM
EM subendothelial deposit ‘fingerprint pattern of cryo[recipitate
Cryoglobulinmic GN Tx?
RP or organ threatening: MP + CYC / RTX
life threatening (lung hemorrhage, hyperviscosity) should have TPE
can IC first before treating HCV, but HIV / HBV should treat with antiviral first
MPGN type?
type I: subendothelial + mesangial
type II: intramembranous EDD + mesangial
type III: mesangial + subendothelial + subepithelial
Mayo clinic classification:
IC: infection HBV / HCV, IE, shunt, abscess, leprosy, meningiococcal, mycoplasma, malaria, haanta, schistsomiasis; autoimmune: SLe, sjogren, RA, PSC; neoplastic: monoclonal gammopathy
Complement related: C3 / DDD, due to CFH, CHI or C3NF
Non IC / complement: healing HUS / TTP, APS, POEMS, TMA, SCA, post transplant
Idiopathic
MPGN IgM predom causes?
Viral related, or RA / Sjrogren
usually IgG3 without LC restriction